Your browser doesn't support javascript.
loading
A real-world study of panobinostat, weekly bortezomib and dexamethasone in a very heavily pretreated population of multiple-myeloma patients.
Bird, Sarah; Pawlyn, Charlotte; Nallamilli, Susanna; Sriskandarajah, Priya; Kaiser, Martin; Yong, Kwee; Popat, Rakesh; Rabin, Neil; Boyd, Kevin.
Affiliation
  • Bird S; The Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Pawlyn C; The Institute of Cancer Research, London, UK.
  • Nallamilli S; The Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Sriskandarajah P; The Institute of Cancer Research, London, UK.
  • Kaiser M; University College London Hospital NHS Foundation Trust, London, UK.
  • Yong K; The Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Popat R; The Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Rabin N; The Institute of Cancer Research, London, UK.
  • Boyd K; University College London Hospital NHS Foundation Trust, London, UK.
Br J Haematol ; 191(5): 927-930, 2020 12.
Article in En | MEDLINE | ID: mdl-33460042

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Multiple Myeloma Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Haematol Year: 2020 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Multiple Myeloma Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Haematol Year: 2020 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom